FIGURE

Fig 5

ID
ZDB-FIG-260118-31
Publication
Menard et al., 2026 - Zebrafish genetic model of neuromuscular degeneration associated with Atrogin-1 expression
Other Figures
All Figure Page
Back to All Figure Page
Fig 5

Atrogin-1-dependent muscle dysfunctions are irreversible in chronically treated adult atrofish.

(A) Brightfield imaging of adult zebrafish trunk after tissue-clearing showing degeneration of skeletal-muscle tissue in one-month-old atrofish treated with tamoxifen (TAM) for 5 months (bottom) compared to TAM-treated control fish (control; top) at 6 months of age. Arrows indicate regions of degeneration. (B) Quantification of the volume of muscle tissue in TAM-treated control fish (n = 6) or atrofish treated with either DMSO (n = 3) or TAM (n = 10). Statistical significance is determined by t-test, two-tailed, unpaired. (C) Representative images of 3D reconstructed trunk skeletal-muscle tissue after chronic TAM treatment in control fish (top) or atrofish (bottom) at 6 months of age. (D) Quantification of the volume expected after 3D reconstruction of atrofish trunk skeletal-muscle tissue (n = 10). Statistical significance is determined by t-test, two-tailed, paired. (E) Representative images of 3D reconstructed trunk skeletal-muscle tissue after chronic TAM treatment in atrofish at 6 months of age. (F, G) Quantification of the number of focal injuries in TAM-treated control fish (n = 6) and TAM-treated atrofish (n = 6) at 6 months of age after 3D construction (F). Quantification of the average volume of injuries in TAM-treated control fish (n = 6) and TAM-treated atrofish (n = 6) at 6 months of age after 3D construction (G). Statistical significance is determined by t-test, two-tailed, unpaired with Welch’s correction. (H) Quantification of the distribution of the injuries identified in (G) in TAM-treated control fish (n = 6) and TAM-treated atrofish (n = 6) at 6 months of age after 3D construction. n in the graphic indicates the number of injuries per biological replicate. Injuries from 6 biological replicates for control or atrofish have been pulled together to determine statistical significance using t-test, two-tailed, unpaired. (I) Representative images of the numbers and sizes of injuries in trunk skeletal-muscle tissue after chronic TAM treatment in control (top) or atrofish (bottom) at 6 months of age. Each color represents a single injury, quantified in (H). (J) Quantification of swimming capacity of control fish and atrofish at 6 months of age treated with either DMSO or 4-OHT for 5 months (n = 19 for each condition). Statistical significance is determined by Mann-Whitney test, two-tailed, unpaired. (K) Quantification of swimming capacity of control fish (n = 9) and atrofish (n = 15) at 9 months of age, treated with TAM for 5 months, i.e., between 1 and 6 months of age, and then treated with either DMSO (ctrl, n = 5; atro, n = 4) or TAM (ctrl, n = 4; atro, n = 11) for an additional 3 months (i.e., until 9 months of age), to test for recovery of swimming function. Statistical significance is determined by a Two-way Anova. Error bars represent s.d. Scale bars: 1 mm.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data
Fish:
Condition:
Observed In:
Stage: Adult

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ PLoS Genet.